MYDECINE

Mydecine Innovations Group (OTCMKTS:MYCOF) Stock Soars 65% in a Month: Now What?

← Back to all news
July 19, 2021

Published at drpgazette.com.

By Sean Dougherty

If you are currently taking a look at stocks which have recorded considerable gains in recent weeks then it might be a good time to take a look at the Mydecine Innovations Group (OTCMKTS:MYCOF) stock. The company is an emerging entity in the biopharma and life sciences space and over the course of the past month or so; it has managed to clock gains of 65%.

Last week the company announced that it is going launch the second version of its virtual health platform later on this month on July 30 through its subsidiary company Mindheap Health.

The health platform in question is meant for providing an infrastructure that can help in the adoption of psychedelics for the purposes of treating wellness as well as mental health issues. The technical director and the interim Chief Executive Officer of the company William Cook spoke about the platform.

He stated that it is a platform that can help in transforming the lives of people. He went on to state that Mindleap is committed to providing people with reliable support for mental health issues that they might face on a daily basis. In light of the gains made by the Mydecine stock in recent weeks, it is a stock that investors could do well to keep in their watch lists.

Market Reaction:

On Friday, MYCOF stock jumped 1.80% at $0.3977 with more than 1 million shares, compared to its average volume of 1.12 million shares. The stock had moved within a range of $0.3849 – 0.4000 after opening the trade at $0.3936. Over the past 52-week, the stock has been trading within a range of $0.1990 – 0.5200.